Results 131 to 140 of about 9,731 (238)

Clinical Presentation and Treatment of a Patient With Prurigo Pigmentosa. [PDF]

Cureus
Rzek D, Hulur I.
europepmc   +1 more source

Serie parasitosis en dermatología Pediculosis

Revista del Hospital Italiano de Buenos Aires
La enfermedad producida por Pediculus humanus capitis, conocida como pediculosis, es una parasitosis específica del ser humano de distribución mundial.
María Luz Bollea Garlatt, Aldana Soledad Vacas, Denise Carolina Valdivia Montero, Evelyn Andrea Zambrano, Paula Enz, Ricardo Galimberti   +5 more
doaj  

Prurigo Pigmentosa Following Bariatric Surgery: A Comprehensive Clinicopathological Review. [PDF]

Dermatol Res Pract
Nagshabandi KN, M Shadid A, Almazro AA, Shadid A, Shadid S, Alakrash L.   +5 more
europepmc   +1 more source

A Rare Case of Dupilumab Monotherapy in Pemphigoid Nodularis and a Comprehensive Literature Review. [PDF]

Cureus
Albthali SM, Alajmi FM, Almutairi S, Al-Sabah H.   +3 more
europepmc   +1 more source

Uso de antibióticos y manifestaciones demartológicas en pacientes atendidos en consulta externa en el Centro Nacional de Dermatología "Dr. Francisco J. Gómez Urcuyo" Managua, Nicaragua Enero a Diciembre 2008 [PDF]

, 2010
Luna Zuniga, Tatiana Valeska, Mejía Florián, Karla Suyén, Salasblanca Quiróz, Frania Cecilia   +2 more
core  

Trastuzumab-associated prurigo nodularis successfully treated with nemolizumab: A case report. [PDF]

JAAD Case Rep
Chen R, Lee MS, Puleo AE, Qureshi A, Laga AC, Nambudiri VE.   +5 more
europepmc   +1 more source

Efficacy and safety of nemolizumab in prurigo nodularis: a systematic review and meta-analysis of randomized controlled trials. [PDF]

An Bras Dermatol
Vieira ACP, Cruz Akabane MAC, Caletti GCG, Heffel KK, Tauana Oliveira E Silva A.   +4 more
europepmc   +1 more source

Prurigo nodularis

The Tohoku Journal of Experimental Medicine, 1951
openaire   +3 more sources

Concurrent Nemolizumab-Induced Cutaneous Adverse Events and Asthma Exacerbation in a Patient With Prurigo Nodularis With Resolution of Both Conditions After Switching to Dupilumab. [PDF]

Cureus
Mima Y, Yamamoto M, Iozumi K.
europepmc   +1 more source

The Absence of Recent Systemic Therapy can be a Significant Risk Factor for Nemolizumab-associated Cutaneous Adverse Events in Patients with Prurigo Nodularis: A Single-centre Retrospective Study. [PDF]

Acta Derm Venereol
Mima Y, Yamamoto M, Iozumi K.
europepmc   +1 more source